ORAMED PHARMACEUTICALS INC.
Develops oral drug delivery systems to convert injectable drugs, like insulin, into capsules.
ORMP | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, 10036 NEW YORK
- Website:
- https://oramed.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Oramed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company specializing in the development of oral drug delivery systems for medications typically administered by injection. The company's proprietary Protein Oral Delivery (POD™) technology is engineered to protect protein-based drugs, such as insulin, from degradation within the gastrointestinal tract, enabling their oral absorption. Oramed's flagship product candidate is an oral insulin capsule for the treatment of type 2 diabetes. By aiming to convert injectable therapies into oral forms, the company seeks to enhance patient comfort, compliance, and safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ORAMED PHARMACEUTICALS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ORAMED PHARMACEUTICALS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ORAMED PHARMACEUTICALS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
